Nano drug deliverer for ampicillin, clavulanic acid, imipenem, penicillin g and ticarcillin

Authors

  • Maryam Derakhshandeh Department of chemistry, Science and research branch, Islamic Azad University, Tehran, Iran
  • Majid Monajjemi Department of Chemical engineering, central Tehran Branch, Islamic Azad University, Tehran, Iran

DOI:

https://doi.org/10.5377/nexo.v33i01.10052

Keywords:

Ampicillin, Clavulanic acid, Imipenem, Penicillin G, Ticarcillin, DFT, NMR, SWCNTs, SWBNNTs, drug delivery

Abstract

Ampicillin belonging to the penicillin group of beta lactam antibiotics. Ampicillin is able to penetrate Gram positive and some Gram-negative bacteria. Imipenem (Primaxin) is an intravenous β-lactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in 1980 Ampicillin, Clavulanic acid, Imipenem, Penicillin G and Ticarcillin properties for the drug delivery with binding to SWCNNTs and SWBNNTs have been studied. Penicillin and its alteration Penicillin G or phenoxyacetic acid for Penicillin V is used for large scale production. Penicillin and other cell wall inhibitors are primarily specific against Gram positive bacteria because of higher percentage of peptidoglycan in the cell walls of these organisms. It was the first member of the carbapenem class of antibiotics. Based on our previous works we have modeled and simulated a drug delivery system of those antibiotics. The investigation of those antibiotics in binding with single-walled carbon nanotube (SWCNT) and SWBNNTs have been studied by theoretical methods. It has been established the best structural and functional of those antibiotics.

Downloads

Download data is not yet available.
Abstract
714
PDF 649

Downloads

Published

2020-07-20

How to Cite

Derakhshandeh, M., & Monajjemi, M. (2020). Nano drug deliverer for ampicillin, clavulanic acid, imipenem, penicillin g and ticarcillin. Nexo Scientific Journal, 33(01), 121–136. https://doi.org/10.5377/nexo.v33i01.10052

Issue

Vol. 33 No. 01 (2020)

Section

Articles

License

The authors who publish in Nexo Scientific Journal agree to the following terms:

  • Authors retain the copyright and grant the journal the right of the first publication under the license Creative Commons Attribution License, which allows others to share the work with a recognition of the authorship of the work and the initial publication in Nexo Scientific Journal.
  • Authors may separately establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, in an institutional repository or a book), with the recognition of the initial publication in Nexo Scientific Journal.
  • Authors are allowed and encouraged to disseminate their works electronically (for example, in institutional repositories or in their own website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published works.